Sloning Biotechnology GmbH

Sloning BioTechnology GmbH is located in Puchheim, in the vicinity of Munich, and currently employs 20 people. The company aims to become a leading provider of synthetic genes, based on its patented, fully automated SlonomicsTM technology.Sloning delivers any desired gene construct that scientists require for transforming their innovative ideas into real projects. Due to the utilisation of double stranded building blocks, highly standardised work flows and industrialised automation technology, gene synthesis is no longer influenced by the sequence of a gene construct. SlonomicsTM allows a fast and reliable synthesis also of GC-rich and repetitive gene sequences. In consequence, Sloning’s gene synthesis service provides real planning security for subsequent research projects and helps our customers to utilise their available time and budgets more efficiently.The sequencing of the human genome has been a milestone in the history of science and has created a tremendous amount of sequence data. Bioinformatics specialists estimate that only about 15% of all known human genes are functionally characterised because no adequate tools do exist for transfering this huge amount of information into knowledge. Whilst high-throughput technologies have accelerated genome analysis and proteomics, functional genomics remains a bottleneck since it relies on slow manual cloning procedures to generate modified gene constructs.

Contact Details: Zeppelinstr. 4 Puchheim 82178 Germany Tel: 49 (89) 80 90 95-0 Fax: 49 (89) 80 90 95-50 Email: info@sloning.de WWW: www.sloning.com/

Recent Publications by Sloning Biotechnology GmbH:
A novel solid phase technology for high-throughput gene synthesis. Eight analogues of 1N,12N-bisethylspermine (BES) with restricted...	15th November, 2008	Sloning BioTechnology GmbH, Zeppelinstrasse 4, Puchheim, Germany.	Biotechniques. 2008 Sep;45(3):340-3. DOI Direct Link
HER-2/neu gene amplification in ovarian tumours: a comprehensive immunohistochemical and FISH analysis on tissue microarrays. AIMS: Data on HER-2/neu overexpression, its correlation to prognosis and...	28th February, 2006	Sloning Biotechnology GmbH, Puchheim, Germany.	Histopathology. 2006 Jan;48(2):149-56. DOI Direct Link

BioNews Results for Sloning Biotechnology GmbH:
TECAN DEUTSCHLAND GmbH: CTI Medtech Award nomination for automated, quality controlled cell culturing system	PRO-4-PRO:  Nov 6 2009 6:29PM Matching: biotechnology gmbh
Phyton Biotech Acquires Assets of Natural Pharmaceuticals, Inc. 10/12/09	American Pharmaceutical Outsourcing:  Oct 14 2009 8:57PM Matching: biotechnology gmbh
Phyton Biotech Acquires Assets of Natural Pharmaceuticals, Inc	Houston Chronicle:  Oct 13 2009 10:40AM Matching: biotechnology gmbh
Phyton Biotech purchases NPIs assets	News-Medical.Net:  Oct 13 2009 6:11AM Matching: biotechnology gmbh
Phyton Biotech bernimmt Anlagen von Natural Pharmaceuticals, Inc	FinanzNachrichten.de:  Oct 13 2009 3:09AM Matching: biotechnology gmbh
Promote your company here: BioNewsCast - Press Release Distribution	→View more Sloning Biotechnology GmbH news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 209 times since April 2007, the link to the organisation's website has been followed 37 times

Search for more companies in Puchheim

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Sloning Biotechnology GmbH